Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Peringkat dalam Saham #33997
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Harga Saham
$0.1502
Terakhir disinkronkan: 2024-11-04
Kapitalisasi Pasar
$6.43M
Perubahan (1 hari)
-5.45%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Renalytix Plc (RNLX)

Kategori

Laba untuk Renalytix Plc (RNLX)
Laba pada Sep 2024 TTM: $-28.67M
Menurut laporan keuangan terbaru dari Renalytix Plc, laba saat ini perusahaan adalah $-28.67M. Pada tahun 2023, perusahaan memperoleh laba sebesar $-46.22M, penurunan dibandingkan dengan laba tahun 2022 sebesar $-45.25M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Renalytix Plc dari 2018 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $-28.67M -14.29%
2024 $-33.45M -27.63%
2023 $-46.22M 2.14%
2022 $-45.25M 26.44%
2021 $-35.79M 237.30%
2020 $-10.61M 62.78%
2019 $-6.52M 1,459.33%
2018 $-418.00K 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$2.04B -7,225.67%
US
$222.34M -875.49%
AU
$295.53M -1,130.77%
US
$-259.89M 806.47%
US
- -
US